Early results following everolimus-eluting bioresorbable vascular scaffold implantation for the treatment of in-stent restenosis

International Journal of Cardiology

Volumn 173, Issue 3, 2014, Pages 513-514

  Ielasi, Alfonso ^a   Latib, Azeem ^b,d   Naganuma, Toru ^b,d   Cortese, Bernardo ^c   Sato, Katsumasa ^b,d   Miyazaki, Tadashi ^b,d   Panoulas, Vasileios F ^b,d   Tespili, Maurizio ^a   Colombo, Antonio ^b,d  

^a BOLOGNINI HOSPITAL   (Italy)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Bioresorbable vascular scaffold; In stent restenosis; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; RAPAMYCIN;

ADULT; AGED; BARE METAL STENT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; DRUG ELUTING STENT; EVEROLIMUS ELUTING STENT; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; LETTER; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STENT THROMBOSIS; TREATMENT RESPONSE; ANALOGS AND DERIVATIVES; CORONARY RESTENOSIS; OPTICAL COHERENCE TOMOGRAPHY; TISSUE SCAFFOLD;

CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; MALE; SIROLIMUS; TISSUE SCAFFOLDS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84899508846     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.03.061     Document Type: Article

References (10)

1. C. Grasso, G.F. Attizzani, and M. Patane et al. First-in-human description of everolimus-eluting bioabsorbable vascular scaffold implantation for the treatment of drug-eluting stent failure: insights from optical coherence tomography Int J Cardiol 168 2013 4490 4491
2. A. Latib, C. Costopoulos, and T. Naganuma et al. Which patients could benefit the most from bioresorbable vascular scaffold implant: from clinical trials to clinical practice Minerva Cardioangiol 61 2013 255 262
3. P.W. Serruys, and Y. Onuma Preliminary data from ABSORB EXTEND: a report of the 12-month clinical outcomes from the first 450 patients enrolled Presented at: EuroPCR; May 23th 2013; Paris, France 2013
4. R. Mehran, G. Dangas, and A.S. Abizaid et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome Circulation 100 1999 1872 1878
5. T. Naganuma, S. Basavarajaiah, and A. Latib et al. Use of BVS in a chronic total occlusion with bifurcation lesion Int J Cardiol 167 2013 e129 e131
6. G. Dangas, and V. Fuster Management of restenosis after coronary intervention Am Heart J 132 1996 428 436
7. C. Stettler, S. Wandel, and S. Allemann et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948
8. L. Mauri, T.S. Silbaugh, and R.E. Wolf et al. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts Circulation 118 2008 1817 1827
9. G. Sarno, B. Lagerqvist, and O. Frobert et al. Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR) Eur Heart J 33 2012 606 613
10. P.W. Serruys, J.A. Ormiston, and Y. Onuma et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet 373 2009 897 910